GSK Lifts Annual Outlook as Q3 Vaccine Sales Soar - TipRanks.com
Pfizer Changes Its Mind, Will Sell Down Stake in GSK's Haleon Unit - Investing.com India
GlaxoSmithKline reportedly looking to sell select antibiotic brands - PMLiVE
The trading activity of the stock GSK between the 26500 − 28500'th... | Download Scientific Diagram
Is GSK a Strong Buy Right Now? | The Motley Fool
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK - MarketWatch
GSK (GSK) Stock Price, News & Info | The Motley Fool
GSK (GSK) Declines More Than Market: Some Information for Investors
GSK: Glaxo SmithKline Share Price Target 2023, 2025, 2027, 2030 to 2050 - Sharedhan
GSK plc - Wikipedia
GSK slapped with 'sell' rating over long-term risks | LSE:GSK, NYSE:GSK
Glaxo plots £8bn move to buy back Beechams stake
Glenmark Pharma & GSK Pharma: Top Stock Recommendation From Aditya Arora | ET Now - YouTube
GSK-HUL deal: HUL shares gain after Horlicks deal; should you buy or sell stock? What brokerages say - Market News | The Financial Express
GSK Raises $1 Billion Selling Shares in Haleon Spinoff - Bloomberg
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
GSK To Sell Poznań Manufacturing Site To Delpharm | Contract Pharma
Why GSK had to sell its Indian consumer health business
GSK Consumer Healthcare's Horlicks sale could prove to be a sticky attraction for some | Mint
GSK agrees £9bn deal for consumer healthcare stake – and may sell Horlicks to buy it
With $1.2B stock sale, GSK offloads more of its stake in consumer health spinoff Haleon | Fierce Pharma
GlaxoSmithKline to leave landmark global HQ after split-up as consumer health business plots £120M new home | Fierce Pharma
GSK Shares Gain on Analyst Upgrade, Price Target Boost - TipRanks.com
GSK shares: Price analysis before buying or selling
